Peripheral joint involvement in psoriatic arthritis patients

Clinical and Experimental Rheumatology

Volumn 33, Issue , 2015, Pages 26-30

  Acosta Felquer, Maria Laura ^a   FitzGerald, Oliver ^b  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Peripheral joint involvement; Psoriatic arthritis

Indexed keywords

ABATACEPT; ADALIMUMAB; APREMILAST; BRODALUMAB; CERTOLIZUMAB PEGOL; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GOLIMUMAB; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PLACEBO; SALAZOSULFAPYRIDINE; SECUKINUMAB; TUMOR NECROSIS FACTOR INHIBITOR; USTEKINUMAB;

ARTHROPATHY; ARTICLE; BONE EROSION; CLINICAL EXAMINATION; CLINICAL FEATURE; DACTYLITIS; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DIGITAL RADIOGRAPHY; HUMAN; INTERPHALANGEAL JOINT; MONARTHRITIS; OSTEOLYSIS; PHASE 3 CLINICAL TRIAL (TOPIC); POLYARTHRITIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHEUMATOID ARTHRITIS; SYNOVITIS; ARTHRITIS, PSORIATIC; ARTHROGRAPHY; DISEASE COURSE; JOINT; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SYNOVIUM;

ARTHRITIS, PSORIATIC; ARTHROGRAPHY; DISEASE PROGRESSION; HUMANS; JOINTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SYNOVIAL MEMBRANE;

EID: 84958177808     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. IBRAHIM G, WAXMAN R, HELLIWELL PS: The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009; 61: 1373-8.
2. SALVARANI C, LO SCOCCO G, MACCHIONI P et al.: Prevalence of psoriatic arthritis in Italian psoriatic patients. J Rheumatol 1995; 22: 1499-503).
3. ZACHARIAE H: Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Clin Dermatol 2003; 4: 441-7.
4. HAROON M, KIRBY B, FitzGERALD O: High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann Rheum Dis 2013; 72: 736-40.
5. SAVOLAINEN E, KAIPIAINEN-SEPPäNEN O, KRöGER L, LUOSUJäRVI R: Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey. J Rheumatol 2003; 30: 2460-8.
6. SöDERLIN MK, BöRJESSON O, KAUTIAINEN H, SKOGH T, LEIRISALO-REPO M: Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann Rheum Dis 2002; 61: 911-5.
7. CHANDRAN V, RAYCHAUDHURI SP: Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 2010; 34: J314.21.
8. HAROON M, WINCHESTER R, GILES JT, HEFFERNAN E, FitzGERALD O: Certain class I HLA alleles and haplotypes implicated in susceptibility play a role in determining specific features of the psoriatic arthritis phenotype. Ann Rheum Dis (2014).
9. CHIU YH, RITCHLIN CT: Biomarkers to diagnose early arthritis in patients with psoriasis. Psoriasis Forum Summer 2012; 18: 2-10.
10. CHIU YH, MENSAH KA, SCHWARZ EM et al.: Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP). J Bone Miner Res 2012; 27: 79-92.
11. MOLL JM, WRIGHT V: Psoriatic arthritis. Semin Arthritis Rheum 1973; 3: 55-78.
12. WRIGHT VMJ: Psoriatic arthritis. In: WRIGHT V, MOLL JM (Eds.) Seronegative polyarthritis. Amsterdam: North Holland Publishing Co (1976).
13. HELLIWELL P, MARCHESONI A, PETERS M, BARKER M, WRIGHT V: A re-evaluation of the osteoarticular manifestations of psoriasis. Br J Rheumatol 1991; 30: 339-45.
14. JONES SM, ARMAS JB, COHEN MG, LOVELL CR, EVISON G, MCHUGH NJ: Psoriatic arthritis: outcome of disease subsets and relation ship of joint disease to nail and skin disease. Br J Rheumatol 1994; 33: 834-9.
15. VEALE D, ROGERS S, FitzGERALD O: Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol 1994; 33: 133-8.
16. KANE D: A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology 2003; 42: 1460-8.
17. REICH K, KRüGER K, MöSSNER R, AUGUSTIN M: Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 2009; 160: 1040-7.
18. KUMAR R, SHARMA A, DOGRA S: Prevalence and clinical patterns of psoriatic arthritis in Indian patients with psoriasis. Indian J Dermatol Venereol Leprol 80: 15-23.
19. McHUGH NJ, BALACHRISHNAN C, JONES SM: Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. Rheumatology (Oxford) 2003; 42: 778-83.
20. HELLIWELL PS, HETTHEN J, SOKOLL K et al.: Joint symmetry in early and late rheumatoid and psoriatic arthritis: comparison with a mathematical model. Arthritis Rheum 2000; 43: 865-71.
21. GLADMAN DD: Psoriatic arthritis. Dermatol Ther 2004; 17: 350-63.
22. KRUEGER GG: Clinical features of psoriatic arthritis. Am J Manag Care 2002; 8: S160-70.
23. HELLIWELL PS, PORTER G, TAYLOR WJ: Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis. Ann Rheum Dis 2007; 66: 113-7.
24. DöNMEZ S, PAMUK ÖN, AKKER M, AK R: Clinical features and types of articular involvement in patients with psoriatic arthritis. Clin Rheumatol 2015; 34: 1091-6.
25. TORRE ALONSO JC, RODRIGUEZ PEREZ A, ARRIBAS CASTRILLO JM, BALLINA GARCIA J, RIESTRA NORIEGA JL, LOPEZ LARREA C: Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients. Br J Rheumatol 1991; 30: 245-50.
26. HADDAD A, CHANDRAN V: Arthritis mutilans. Curr Rheumatol Rep 2013; 15: 321.
27. FitzGERALD O, MEASE PJ, HELLIWELL PS, CHANDRAN V: GRAPPA 2013 Annual Meeting, rheumatology updates: psoriatic arthritis (PsA) biomarker project, arthritis mutilans, PsA-peripheral spondyloarthritis epidemiology project. J Rheumatol 2014; 41: 1244-8.
28. JADON DR, SHADDICK G, TILLETT W et al.: Psoriatic arthritis mutilans: characteristics and natural radiographic history. J Rheumatol 2015.
29. CHANDRAN V, GLADMAN DD, HELLIWELL PS, GUDBJöRNSSON B: Arthritis mutilans: a report from the GRAPPA 2012 annual meeting. J Rheumatol 2013; 40: 1419-22.
30. KAVANAUGH A, MEASE P: Treatment of psoriatic arthritis with tumor necrosis factor inhibitors: longer-term outcomes including enthesitis and dactylitis with golimumab treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GOREVEAL). J Rheumatol 2012; (Suppl. 89): 90-3.
31. GLADMAN DD, CHANDRAN V: Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program. Rheumatology (Oxford) 2011; 50: 25-31.
32. OLIVIERI I, SCARANO E, PADULA A, GIASI V, PRIOLO F: Dactylitis, a term for different digit diseases. Scand J Rheumatol 35: 333-40.
33. MEASE PJ, GARG A, GLADMAN DD, HELLIWELL PS: Development of simple clinical criteria for the definition of inflammatory arthritis, enthesitis, dactylitis, and spondylitis: a report from the GRAPPA 2012 annual meeting. J Rheumatol 2013; 40: 1442-5.
34. GLADMAN DD, ZIOUZINA O, THAVANESWARAN A, CHANDRAN V: Dactylitis in psoriatic arthritis: prevalence and response to therapy in the biologic era. J Rheumatol 2013; 40: 1357-9.
35. BROCKBANK JE, STEIN M, SCHENTAG CT, GLADMAN DD: Dactylitis in psoriatic arthritis: a marker for disease severity? Ann Rheum Dis 2005; 64: 188-90.
36. PAYET J, GOSSEC L, PATERNOTTE S et al.: Prevalence and clinical characteristics of dactylitis in spondylarthritis: a descriptive analysis of 275 patients. Clin Exp Rheumatol 2012; 30: 191-6.
37. HELLIWELL PS, FIRTH J, IBRAHIM GH, MELSOM RD, SHAH I, TURNER DE: Development of an assessment tool for dactylitis in patients with psoriatic arthritis. J Rheumatol 2005; 32: 1745-50.
38. SIEGEL EL, ORBAI A-M, RITCHLIN CT: Targeting extra-articular manifestations in PsA: a closer look at enthesitis and dactylitis. Curr Opin Rheumatol 2015; 27: 111-7.
39. Van KUIJK AWR, REINDERS-BLANKERT P, SMEETS TJM, DIJKMANS BAC, TAK PP: Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. Ann Rheum Dis 2006; 65: 1551-7.
40. COSTELLO P, BRESNIHAN B, O'FARRELLY C, FitzGERALD O: Predominance of CD8+ T lymphocytes in psoriatic arthritis. J Rheumatol 1999; 26: 1117-24.
41. VEALE D, YANNI G, ROGERS S, BARNES L, BRESNIHAN B, FITZGERALD O: Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum 1993; 36: 893-900.
42. RITCHLIN CT, HAAS-SMITH SA, LI P, HICKS DG, SCHWARZ EM: Mechanisms of TNF-alpha-and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 2003; 111: 821-31.
43. VANDOOREN B, CANTAERT T, NOORDENBOS T, TAK PP, BAETEN D: The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation. Arthritis Rheum 2008; 58: 718-29.
44. KRUITHOF E, BAETEN D, DE RYCKE L et al.: Synovial histopathology of psoriatic arthritis, both oligo-and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis. Arthritis Res Ther 2005; 7: R569-80.
45. WIELL C, SZKUDLAREK M, HASSELQUIST M et al.: Ultrasonography, magnetic resonance imaging, radiography, and clinical assessment of inflammatory and destructive changes in fingers and toes of patients with psoriatic arthritis. Arthritis Res Ther 2007; 9: R119.
46. GUTIERREZ M, FILIPPUCCI E, DE ANGELIS R, FILOSA G, KANE D, GRASSI W: A sonographic spectrum of psoriatic arthritis: 'the five targets'. Clin Rheumatol 2010; 29: 133-42.
47. McQUEEN F, LASSERE M, ØSTERGAARD M: Magnetic resonance imaging in psoriatic arthritis: a review of the literature. Arthritis Res Ther 2006; 8: 207.
48. MARZO-ORTEGA H, TANNER SF, RHODES LA et al.: Magnetic resonance imaging in the assessment of metacarpophalangeal joint disease in early psoriatic and rheumatoid arthritis. Scand J Rheumatol 38: 79-83.
49. FINZEL S, ENGLBRECHT M, ENGELKE K, STACH C, SCHETT G: A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis. Ann Rheum Dis 2011; 70: 122-7.
50. GLADMAN DD, FAREWELL VT, NADEAU C: Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model. J Rheumatol 1995; 22: 675-9.
51. PUNZI L, PIANON M, ROSSINI P, SCHIAVON F, GAMBARI PF: Clinical and laboratory manifestations of elderly onset psoriatic arthritis: a comparison with younger onset disease. Ann Rheum Dis 1999: 58: 226-9.
52. COATES LC, KAVANAUGH A, RITCHLIN CT: Systematic review of treatments for psoriatic arthritis: 2014 update for the GRAPPA. J Rheumatol 2014; 41: 2273-6.
53. SOLOMON DH, BITTON A, KATZ JN, RADNER H, BROWN EM, FRAENKEL L: Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis? Arthritis Rheumatol 2014; 66: 775-82.
54. COATES LC: Treating to target in psoriatic arthritis. Curr Opin Rheumatol 2015; 27: 107-10.